InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.00%
)
US TECH 100
17,696.80
(
0.32%
)
Dow Jones
39,387.76
(
0.00%
)
Brent Oil
83.90
(
-0.07%
)
Bitcoin
62,946.52
(
-0.16%
)
Post# of 118364
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

SidVicious

Send PM Follow Ignore
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

SidVicious

Re: Jeremyan7 post# 31688

Tuesday, 12/05/2017 9:45:45 AM

Tuesday, December 05, 2017 9:45:45 AM

Post# of 118364
That is incorrect. Properly run biotechs, unlike Regen, would be much farther along than where Regen is now.

Properly run biotechs tend to have MONEY to fund their clinical trials etc.

But not Regen. David Koos is trying to reinvent the wheel. That's a recipe for failure and so far David has failed at every step.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!